Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -14.48%467.53K | -538.21%-789.5K | -72.22%165.47K | 54.77%2.24M | -58.97%919.99K | -32.79%546.71K | 126.18%180.17K | 164.83%595.62K | -34.67%1.45M | 267.29%2.24M |
| Net income from continuing operations | -229.43%-158.77K | -130.12%-147.7K | -121.83%-49.34K | -152.11%-4.28M | -207.56%-5.12M | 1,974.51%122.67K | 758.89%490.41K | 540.21%226K | -207.43%-1.7M | -1,115.31%-1.66M |
| Operating gains losses | ---- | ---- | ---- | -60.00%-40K | --0 | --0 | --0 | ---40K | ---25K | ---- |
| Depreciation and amortization | 14.50%366.03K | -21.81%331.59K | -4.94%325.83K | 11.10%1.83M | 12.04%742.64K | -4.45%319.67K | 44.21%424.06K | -3.44%342.76K | 17.78%1.65M | 25.92%662.85K |
| Asset impairment expenditure | ---- | ---- | ---- | 346.43%4.5M | ---- | ---- | ---- | ---- | --1.01M | ---- |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | ---- | ---- | ---- | 34.86%80.87K | 119.85%120.34K | -3,249.61%-40K | --0 | -76.02%531 | -24.84%59.96K | -20.62%54.74K |
| Change In working capital | 125.08%234.94K | -32.56%-973.39K | -267.37%-111.01K | -64.80%152.1K | -67.18%715.69K | -77.87%104.38K | 19.26%-734.3K | 105.06%66.33K | 166.09%432.07K | 544.54%2.18M |
| -Change in receivables | -34.66%116.23K | -125.14%-11.85K | 114.75%59.84K | -100.41%-1.32K | 518.79%179.2K | 60.16%177.89K | -10.09%47.13K | -414.66%-405.54K | 356.22%321.34K | 210.55%28.96K |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Change in prepaid assets | --0 | -19,118.33%-434.14K | 43.54%-48.69K | 425.20%116.55K | 266.67%278.56K | -178.97%-73.51K | -102.78%-2.26K | -99.63%-86.24K | 68.11%-35.84K | -1,653.99%-167.13K |
| -Change in payables and accrued expense | 11,870,600.00%118.71K | 32.31%-527.4K | -121.89%-122.16K | -74.85%36.86K | -88.88%257.93K | -100.00%-1 | 25.31%-779.18K | 139.96%558.11K | 134.43%146.57K | 574.05%2.32M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -14.48%467.53K | -538.21%-789.5K | -72.22%165.47K | 54.77%2.24M | -58.97%919.99K | -32.79%546.71K | 126.18%180.17K | 164.83%595.62K | -34.67%1.45M | 267.29%2.24M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -53.88%-1.68M | 30.35%-495.82K | 84.09%-609.1K | -1.55%-5.35M | 145.37%278.43K | 17.90%-1.09M | 11.24%-711.93K | -51.53%-3.83M | 36.66%-5.27M | 88.93%-613.75K |
| Net PPE purchase and sale | --0 | --0 | --0 | -66.52%-274.5K | --0 | --42.5K | --0 | ---317K | 78.23%-164.84K | 38.83%-164.84K |
| Net other investing changes | -78.45%1.11M | 30.35%-495.82K | 82.66%-609.1K | 0.54%-5.08M | ---6.02M | --5.17M | 11.24%-711.93K | -38.98%-3.51M | 32.50%-5.11M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -53.88%-1.68M | 30.35%-495.82K | 84.09%-609.1K | -1.55%-5.35M | 145.37%278.43K | 17.90%-1.09M | 11.24%-711.93K | -51.53%-3.83M | 36.66%-5.27M | 88.93%-613.75K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 184.49%1.13M | 1,278,509.09%1.13M | 0 | 1,691.31%3.97M | 81.45%-395.45K | 512.80%395.45K | 99.91%-88 | 91.32%3.97M | -102.43%-249.36K | -2,125.42%-2.13M |
| Net issuance payments of debt | --1.13M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --0 | --0 | --0 | --4.16M | --1 | --0 | --0 | --4.16M | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --146.25K | --0 |
| Net other financing activities | ---- | ---- | ---- | 52.37%-188.44K | 81.45%-395.45K | 512.80%395.45K | 99.91%-88 | -109.77%-188.35K | 12.16%-395.61K | -2,125.42%-2.13M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 184.49%1.13M | 1,278,509.09%1.13M | --0 | 1,691.31%3.97M | 81.45%-395.45K | 512.80%395.45K | 99.91%-88 | 91.32%3.97M | -102.43%-249.36K | -2,125.42%-2.13M |
| Net cash flow | ||||||||||
| Beginning cash position | 11.92%482.5K | -33.25%642.82K | 376.57%1.09M | -94.70%227.97K | -61.24%283.47K | -67.86%431.12K | -67.10%962.97K | -94.70%227.97K | 2,852.18%4.3M | -92.11%731.33K |
| Current changes in cash | 42.80%-84.45K | 69.86%-160.32K | -160.36%-443.63K | 121.09%858.48K | 259.53%802.98K | 75.79%-147.65K | 66.47%-531.85K | 153.60%735K | -198.02%-4.07M | 89.87%-503.35K |
| End cash Position | 40.42%398.04K | 11.92%482.5K | -33.25%642.82K | 376.57%1.09M | 376.57%1.09M | -61.24%283.47K | -67.86%431.12K | -67.10%962.97K | -94.70%227.97K | -94.70%227.97K |
| Free cash from | 59.32%-2.32M | -538.21%-789.5K | -40.61%165.47K | 62.10%1.97M | 8.36%7.22M | -48.63%-5.71M | 126.18%180.17K | 130.33%278.62K | -16.88%1.21M | 187.31%6.66M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.